nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—Naloxone—TLR4—Crohn's disease	0.0229	0.889	CrCbGaD
Oxycodone—Coma—Mesalazine—Crohn's disease	0.00557	0.00602	CcSEcCtD
Oxycodone—Hypertonia—Mesalazine—Crohn's disease	0.00535	0.00578	CcSEcCtD
Oxycodone—Lymphadenopathy—Mesalazine—Crohn's disease	0.00519	0.00561	CcSEcCtD
Oxycodone—Immune system disorder—Mercaptopurine—Crohn's disease	0.0051	0.00551	CcSEcCtD
Oxycodone—Disorientation—Mesalazine—Crohn's disease	0.00495	0.00535	CcSEcCtD
Oxycodone—Malnutrition—Mercaptopurine—Crohn's disease	0.00491	0.00531	CcSEcCtD
Oxycodone—Libido decreased—Mesalazine—Crohn's disease	0.00477	0.00516	CcSEcCtD
Oxycodone—Increased appetite—Mesalazine—Crohn's disease	0.00471	0.00509	CcSEcCtD
Oxycodone—Thirst—Mesalazine—Crohn's disease	0.00465	0.00503	CcSEcCtD
Oxycodone—Dermatitis bullous—Mesalazine—Crohn's disease	0.00463	0.00501	CcSEcCtD
Oxycodone—Hepatomegaly—Prednisone—Crohn's disease	0.00456	0.00493	CcSEcCtD
Oxycodone—Arthritis—Mesalazine—Crohn's disease	0.00456	0.00492	CcSEcCtD
Oxycodone—Anaemia—Mercaptopurine—Crohn's disease	0.00454	0.00491	CcSEcCtD
Oxycodone—Leukopenia—Mercaptopurine—Crohn's disease	0.0044	0.00475	CcSEcCtD
Oxycodone—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.00439	0.00475	CcSEcCtD
Oxycodone—Migraine—Mesalazine—Crohn's disease	0.00436	0.00471	CcSEcCtD
Oxycodone—Affect lability—Mesalazine—Crohn's disease	0.00436	0.00471	CcSEcCtD
Oxycodone—Face oedema—Mesalazine—Crohn's disease	0.00427	0.00462	CcSEcCtD
Oxycodone—Mood swings—Mesalazine—Crohn's disease	0.00419	0.00453	CcSEcCtD
Oxycodone—Arthralgia—Mercaptopurine—Crohn's disease	0.00418	0.00452	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00415	0.00449	CcSEcCtD
Oxycodone—Dry skin—Mesalazine—Crohn's disease	0.00406	0.00439	CcSEcCtD
Oxycodone—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00404	0.00437	CcSEcCtD
Oxycodone—Abdominal pain upper—Mesalazine—Crohn's disease	0.00404	0.00437	CcSEcCtD
Oxycodone—Oedema—Mercaptopurine—Crohn's disease	0.00401	0.00433	CcSEcCtD
Oxycodone—Breast disorder—Mesalazine—Crohn's disease	0.004	0.00432	CcSEcCtD
Oxycodone—Nasopharyngitis—Mesalazine—Crohn's disease	0.00396	0.00428	CcSEcCtD
Oxycodone—Gastritis—Mesalazine—Crohn's disease	0.00392	0.00423	CcSEcCtD
Oxycodone—Skin disorder—Mercaptopurine—Crohn's disease	0.00389	0.00421	CcSEcCtD
Oxycodone—Endocrine disorder—Prednisone—Crohn's disease	0.00389	0.00421	CcSEcCtD
Oxycodone—Abdominal distension—Mesalazine—Crohn's disease	0.00385	0.00416	CcSEcCtD
Oxycodone—Asthma—Mesalazine—Crohn's disease	0.00383	0.00413	CcSEcCtD
Oxycodone—Dysphagia—Mesalazine—Crohn's disease	0.00383	0.00413	CcSEcCtD
Oxycodone—Influenza—Mesalazine—Crohn's disease	0.00383	0.00413	CcSEcCtD
Oxycodone—Anorexia—Mercaptopurine—Crohn's disease	0.00382	0.00413	CcSEcCtD
Oxycodone—Pneumonia—Azathioprine—Crohn's disease	0.00377	0.00407	CcSEcCtD
Oxycodone—Bronchospasm—Mesalazine—Crohn's disease	0.00376	0.00407	CcSEcCtD
Oxycodone—Delirium—Prednisone—Crohn's disease	0.00375	0.00405	CcSEcCtD
Oxycodone—Infestation—Azathioprine—Crohn's disease	0.00375	0.00405	CcSEcCtD
Oxycodone—Infestation NOS—Azathioprine—Crohn's disease	0.00375	0.00405	CcSEcCtD
Oxycodone—Bronchitis—Mesalazine—Crohn's disease	0.00368	0.00398	CcSEcCtD
Oxycodone—Amenorrhoea—Prednisone—Crohn's disease	0.00367	0.00397	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00365	0.00395	CcSEcCtD
Oxycodone—Dysuria—Mesalazine—Crohn's disease	0.00358	0.00387	CcSEcCtD
Oxycodone—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00354	0.00383	CcSEcCtD
Oxycodone—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00349	0.00377	CcSEcCtD
Oxycodone—Decreased appetite—Mercaptopurine—Crohn's disease	0.00349	0.00377	CcSEcCtD
Oxycodone—Weight decreased—Mesalazine—Crohn's disease	0.00346	0.00374	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00346	0.00374	CcSEcCtD
Oxycodone—Pneumonia—Mesalazine—Crohn's disease	0.00343	0.00371	CcSEcCtD
Oxycodone—Infestation NOS—Mesalazine—Crohn's disease	0.00341	0.00369	CcSEcCtD
Oxycodone—Infestation—Mesalazine—Crohn's disease	0.00341	0.00369	CcSEcCtD
Oxycodone—Haemoglobin—Azathioprine—Crohn's disease	0.00338	0.00365	CcSEcCtD
Oxycodone—Haemorrhage—Azathioprine—Crohn's disease	0.00336	0.00363	CcSEcCtD
Oxycodone—Stomatitis—Mesalazine—Crohn's disease	0.00333	0.00359	CcSEcCtD
Oxycodone—Urinary tract infection—Mesalazine—Crohn's disease	0.00332	0.00358	CcSEcCtD
Oxycodone—Sweating—Mesalazine—Crohn's disease	0.00327	0.00353	CcSEcCtD
Oxycodone—Haematuria—Mesalazine—Crohn's disease	0.00325	0.00352	CcSEcCtD
Oxycodone—Hiccups—Prednisone—Crohn's disease	0.00323	0.00349	CcSEcCtD
Oxycodone—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00323	0.00349	CcSEcCtD
Oxycodone—Epistaxis—Mesalazine—Crohn's disease	0.00322	0.00348	CcSEcCtD
Oxycodone—Sinusitis—Mesalazine—Crohn's disease	0.0032	0.00346	CcSEcCtD
Oxycodone—Body temperature increased—Mercaptopurine—Crohn's disease	0.00317	0.00342	CcSEcCtD
Oxycodone—Haemoglobin—Mesalazine—Crohn's disease	0.00308	0.00333	CcSEcCtD
Oxycodone—Rhinitis—Mesalazine—Crohn's disease	0.00307	0.00332	CcSEcCtD
Oxycodone—Fluid retention—Prednisone—Crohn's disease	0.00306	0.00331	CcSEcCtD
Oxycodone—Haemorrhage—Mesalazine—Crohn's disease	0.00306	0.00331	CcSEcCtD
Oxycodone—Hepatitis—Mesalazine—Crohn's disease	0.00306	0.00331	CcSEcCtD
Oxycodone—Pharyngitis—Mesalazine—Crohn's disease	0.00304	0.00328	CcSEcCtD
Oxycodone—Immune system disorder—Azathioprine—Crohn's disease	0.00304	0.00328	CcSEcCtD
Oxycodone—Mediastinal disorder—Azathioprine—Crohn's disease	0.00303	0.00327	CcSEcCtD
Oxycodone—Urinary tract disorder—Mesalazine—Crohn's disease	0.00302	0.00327	CcSEcCtD
Oxycodone—Oedema peripheral—Mesalazine—Crohn's disease	0.00302	0.00326	CcSEcCtD
Oxycodone—Chills—Azathioprine—Crohn's disease	0.00302	0.00326	CcSEcCtD
Oxycodone—Connective tissue disorder—Mesalazine—Crohn's disease	0.00301	0.00325	CcSEcCtD
Oxycodone—Urethral disorder—Mesalazine—Crohn's disease	0.003	0.00324	CcSEcCtD
Oxycodone—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00295	0.00319	CcSEcCtD
Oxycodone—Eye disorder—Mesalazine—Crohn's disease	0.00286	0.00309	CcSEcCtD
Oxycodone—Naloxone—ALB—Crohn's disease	0.00286	0.111	CrCbGaD
Oxycodone—Tinnitus—Mesalazine—Crohn's disease	0.00286	0.00309	CcSEcCtD
Oxycodone—Cardiac disorder—Mesalazine—Crohn's disease	0.00284	0.00307	CcSEcCtD
Oxycodone—Hyperkinesia—Prednisone—Crohn's disease	0.00281	0.00304	CcSEcCtD
Oxycodone—Sepsis—Prednisone—Crohn's disease	0.0028	0.00303	CcSEcCtD
Oxycodone—Angiopathy—Mesalazine—Crohn's disease	0.00278	0.003	CcSEcCtD
Oxycodone—Euphoric mood—Prednisone—Crohn's disease	0.00277	0.003	CcSEcCtD
Oxycodone—Immune system disorder—Mesalazine—Crohn's disease	0.00277	0.00299	CcSEcCtD
Oxycodone—Mediastinal disorder—Mesalazine—Crohn's disease	0.00276	0.00298	CcSEcCtD
Oxycodone—Chills—Mesalazine—Crohn's disease	0.00275	0.00297	CcSEcCtD
Oxycodone—Diarrhoea—Mercaptopurine—Crohn's disease	0.00274	0.00296	CcSEcCtD
Oxycodone—Ill-defined disorder—Azathioprine—Crohn's disease	0.00272	0.00293	CcSEcCtD
Oxycodone—Thrombophlebitis—Prednisone—Crohn's disease	0.00271	0.00292	CcSEcCtD
Oxycodone—Anaemia—Azathioprine—Crohn's disease	0.00271	0.00292	CcSEcCtD
Oxycodone—Mental disorder—Mesalazine—Crohn's disease	0.00268	0.0029	CcSEcCtD
Oxycodone—Malaise—Azathioprine—Crohn's disease	0.00264	0.00285	CcSEcCtD
Oxycodone—Flatulence—Mesalazine—Crohn's disease	0.00263	0.00284	CcSEcCtD
Oxycodone—Leukopenia—Azathioprine—Crohn's disease	0.00262	0.00283	CcSEcCtD
Oxycodone—Tension—Mesalazine—Crohn's disease	0.00262	0.00283	CcSEcCtD
Oxycodone—Dysgeusia—Mesalazine—Crohn's disease	0.00261	0.00282	CcSEcCtD
Oxycodone—Nervousness—Mesalazine—Crohn's disease	0.00259	0.0028	CcSEcCtD
Oxycodone—Back pain—Mesalazine—Crohn's disease	0.00258	0.00279	CcSEcCtD
Oxycodone—Muscle spasms—Mesalazine—Crohn's disease	0.00256	0.00277	CcSEcCtD
Oxycodone—Vomiting—Mercaptopurine—Crohn's disease	0.00255	0.00275	CcSEcCtD
Oxycodone—Injury—Prednisone—Crohn's disease	0.00255	0.00275	CcSEcCtD
Oxycodone—Rash—Mercaptopurine—Crohn's disease	0.00253	0.00273	CcSEcCtD
Oxycodone—Dermatitis—Mercaptopurine—Crohn's disease	0.00253	0.00273	CcSEcCtD
Oxycodone—Tremor—Mesalazine—Crohn's disease	0.0025	0.0027	CcSEcCtD
Oxycodone—Increased appetite—Prednisone—Crohn's disease	0.00249	0.00269	CcSEcCtD
Oxycodone—Amnesia—Prednisone—Crohn's disease	0.00249	0.00269	CcSEcCtD
Oxycodone—Arthralgia—Azathioprine—Crohn's disease	0.00249	0.00269	CcSEcCtD
Oxycodone—Myalgia—Azathioprine—Crohn's disease	0.00249	0.00269	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00248	0.00267	CcSEcCtD
Oxycodone—Ill-defined disorder—Mesalazine—Crohn's disease	0.00247	0.00267	CcSEcCtD
Oxycodone—Anaemia—Mesalazine—Crohn's disease	0.00246	0.00266	CcSEcCtD
Oxycodone—Discomfort—Azathioprine—Crohn's disease	0.00246	0.00266	CcSEcCtD
Oxycodone—Angioedema—Mesalazine—Crohn's disease	0.00244	0.00263	CcSEcCtD
Oxycodone—Malaise—Mesalazine—Crohn's disease	0.0024	0.0026	CcSEcCtD
Oxycodone—Cardiac failure—Prednisone—Crohn's disease	0.0024	0.00259	CcSEcCtD
Oxycodone—Vertigo—Mesalazine—Crohn's disease	0.0024	0.00259	CcSEcCtD
Oxycodone—Syncope—Mesalazine—Crohn's disease	0.00239	0.00258	CcSEcCtD
Oxycodone—Leukopenia—Mesalazine—Crohn's disease	0.00239	0.00258	CcSEcCtD
Oxycodone—Nausea—Mercaptopurine—Crohn's disease	0.00238	0.00257	CcSEcCtD
Oxycodone—Infection—Azathioprine—Crohn's disease	0.00237	0.00256	CcSEcCtD
Oxycodone—Palpitations—Mesalazine—Crohn's disease	0.00236	0.00255	CcSEcCtD
Oxycodone—Loss of consciousness—Mesalazine—Crohn's disease	0.00234	0.00253	CcSEcCtD
Oxycodone—Cough—Mesalazine—Crohn's disease	0.00233	0.00251	CcSEcCtD
Oxycodone—Skin disorder—Azathioprine—Crohn's disease	0.00232	0.00251	CcSEcCtD
Oxycodone—Affect lability—Prednisone—Crohn's disease	0.00231	0.00249	CcSEcCtD
Oxycodone—Arthralgia—Mesalazine—Crohn's disease	0.00227	0.00245	CcSEcCtD
Oxycodone—Chest pain—Mesalazine—Crohn's disease	0.00227	0.00245	CcSEcCtD
Oxycodone—Myalgia—Mesalazine—Crohn's disease	0.00227	0.00245	CcSEcCtD
Oxycodone—Anxiety—Mesalazine—Crohn's disease	0.00226	0.00244	CcSEcCtD
Oxycodone—Face oedema—Prednisone—Crohn's disease	0.00226	0.00244	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00225	0.00244	CcSEcCtD
Oxycodone—Discomfort—Mesalazine—Crohn's disease	0.00224	0.00242	CcSEcCtD
Oxycodone—Irritability—Prednisone—Crohn's disease	0.00224	0.00242	CcSEcCtD
Oxycodone—Hypotension—Azathioprine—Crohn's disease	0.00223	0.00241	CcSEcCtD
Oxycodone—Cardiac arrest—Prednisone—Crohn's disease	0.00223	0.00241	CcSEcCtD
Oxycodone—Dry mouth—Mesalazine—Crohn's disease	0.00222	0.0024	CcSEcCtD
Oxycodone—Mood swings—Prednisone—Crohn's disease	0.00222	0.0024	CcSEcCtD
Oxycodone—Confusional state—Mesalazine—Crohn's disease	0.00219	0.00237	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00218	0.00235	CcSEcCtD
Oxycodone—Anaphylactic shock—Mesalazine—Crohn's disease	0.00218	0.00235	CcSEcCtD
Oxycodone—Oedema—Mesalazine—Crohn's disease	0.00218	0.00235	CcSEcCtD
Oxycodone—Infection—Mesalazine—Crohn's disease	0.00216	0.00234	CcSEcCtD
Oxycodone—Dry skin—Prednisone—Crohn's disease	0.00215	0.00232	CcSEcCtD
Oxycodone—Shock—Mesalazine—Crohn's disease	0.00214	0.00231	CcSEcCtD
Oxycodone—Nervous system disorder—Mesalazine—Crohn's disease	0.00213	0.00231	CcSEcCtD
Oxycodone—Tachycardia—Mesalazine—Crohn's disease	0.00212	0.00229	CcSEcCtD
Oxycodone—Skin disorder—Mesalazine—Crohn's disease	0.00211	0.00228	CcSEcCtD
Oxycodone—Hyperhidrosis—Mesalazine—Crohn's disease	0.0021	0.00227	CcSEcCtD
Oxycodone—Anorexia—Mesalazine—Crohn's disease	0.00207	0.00224	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00206	0.00223	CcSEcCtD
Oxycodone—Abdominal distension—Prednisone—Crohn's disease	0.00204	0.0022	CcSEcCtD
Oxycodone—Hypotension—Mesalazine—Crohn's disease	0.00203	0.0022	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00198	0.00214	CcSEcCtD
Oxycodone—Feeling abnormal—Azathioprine—Crohn's disease	0.00197	0.00213	CcSEcCtD
Oxycodone—Insomnia—Mesalazine—Crohn's disease	0.00197	0.00213	CcSEcCtD
Oxycodone—Paraesthesia—Mesalazine—Crohn's disease	0.00195	0.00211	CcSEcCtD
Oxycodone—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00195	0.00211	CcSEcCtD
Oxycodone—Dyspnoea—Mesalazine—Crohn's disease	0.00194	0.0021	CcSEcCtD
Oxycodone—Somnolence—Mesalazine—Crohn's disease	0.00193	0.00209	CcSEcCtD
Oxycodone—Dyspepsia—Mesalazine—Crohn's disease	0.00192	0.00207	CcSEcCtD
Oxycodone—Decreased appetite—Mesalazine—Crohn's disease	0.00189	0.00204	CcSEcCtD
Oxycodone—Body temperature increased—Azathioprine—Crohn's disease	0.00189	0.00204	CcSEcCtD
Oxycodone—Abdominal pain—Azathioprine—Crohn's disease	0.00189	0.00204	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00188	0.00203	CcSEcCtD
Oxycodone—Fatigue—Mesalazine—Crohn's disease	0.00188	0.00203	CcSEcCtD
Oxycodone—Erectile dysfunction—Prednisone—Crohn's disease	0.00186	0.00201	CcSEcCtD
Oxycodone—Pain—Mesalazine—Crohn's disease	0.00186	0.00201	CcSEcCtD
Oxycodone—Constipation—Mesalazine—Crohn's disease	0.00186	0.00201	CcSEcCtD
Oxycodone—Weight decreased—Prednisone—Crohn's disease	0.00183	0.00198	CcSEcCtD
Oxycodone—Hyperglycaemia—Prednisone—Crohn's disease	0.00183	0.00197	CcSEcCtD
Oxycodone—Feeling abnormal—Mesalazine—Crohn's disease	0.00179	0.00194	CcSEcCtD
Oxycodone—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00178	0.00192	CcSEcCtD
Oxycodone—Hypersensitivity—Azathioprine—Crohn's disease	0.00176	0.0019	CcSEcCtD
Oxycodone—Urticaria—Mesalazine—Crohn's disease	0.00173	0.00187	CcSEcCtD
Oxycodone—Abdominal pain—Mesalazine—Crohn's disease	0.00172	0.00186	CcSEcCtD
Oxycodone—Body temperature increased—Mesalazine—Crohn's disease	0.00172	0.00186	CcSEcCtD
Oxycodone—Bradycardia—Prednisone—Crohn's disease	0.00165	0.00178	CcSEcCtD
Oxycodone—Diarrhoea—Azathioprine—Crohn's disease	0.00163	0.00177	CcSEcCtD
Oxycodone—Haemoglobin—Prednisone—Crohn's disease	0.00163	0.00176	CcSEcCtD
Oxycodone—Haemorrhage—Prednisone—Crohn's disease	0.00162	0.00175	CcSEcCtD
Oxycodone—Hallucination—Prednisone—Crohn's disease	0.00161	0.00174	CcSEcCtD
Oxycodone—Hypersensitivity—Mesalazine—Crohn's disease	0.0016	0.00173	CcSEcCtD
Oxycodone—Connective tissue disorder—Prednisone—Crohn's disease	0.00159	0.00172	CcSEcCtD
Oxycodone—Dizziness—Azathioprine—Crohn's disease	0.00158	0.00171	CcSEcCtD
Oxycodone—Asthenia—Mesalazine—Crohn's disease	0.00156	0.00169	CcSEcCtD
Oxycodone—Pruritus—Mesalazine—Crohn's disease	0.00154	0.00166	CcSEcCtD
Oxycodone—Vomiting—Azathioprine—Crohn's disease	0.00152	0.00164	CcSEcCtD
Oxycodone—Eye disorder—Prednisone—Crohn's disease	0.00151	0.00164	CcSEcCtD
Oxycodone—Rash—Azathioprine—Crohn's disease	0.00151	0.00163	CcSEcCtD
Oxycodone—Dermatitis—Azathioprine—Crohn's disease	0.0015	0.00163	CcSEcCtD
Oxycodone—Flushing—Prednisone—Crohn's disease	0.0015	0.00163	CcSEcCtD
Oxycodone—Headache—Azathioprine—Crohn's disease	0.0015	0.00162	CcSEcCtD
Oxycodone—Diarrhoea—Mesalazine—Crohn's disease	0.00149	0.00161	CcSEcCtD
Oxycodone—Angiopathy—Prednisone—Crohn's disease	0.00147	0.00159	CcSEcCtD
Oxycodone—Immune system disorder—Prednisone—Crohn's disease	0.00146	0.00158	CcSEcCtD
Oxycodone—Dizziness—Mesalazine—Crohn's disease	0.00144	0.00155	CcSEcCtD
Oxycodone—Mental disorder—Prednisone—Crohn's disease	0.00142	0.00153	CcSEcCtD
Oxycodone—Nausea—Azathioprine—Crohn's disease	0.00142	0.00153	CcSEcCtD
Oxycodone—Malnutrition—Prednisone—Crohn's disease	0.00141	0.00152	CcSEcCtD
Oxycodone—Vomiting—Mesalazine—Crohn's disease	0.00138	0.0015	CcSEcCtD
Oxycodone—Rash—Mesalazine—Crohn's disease	0.00137	0.00148	CcSEcCtD
Oxycodone—Dermatitis—Mesalazine—Crohn's disease	0.00137	0.00148	CcSEcCtD
Oxycodone—Headache—Mesalazine—Crohn's disease	0.00136	0.00147	CcSEcCtD
Oxycodone—Ill-defined disorder—Prednisone—Crohn's disease	0.00131	0.00141	CcSEcCtD
Oxycodone—Anaemia—Prednisone—Crohn's disease	0.0013	0.00141	CcSEcCtD
Oxycodone—Agitation—Prednisone—Crohn's disease	0.0013	0.0014	CcSEcCtD
Oxycodone—Nausea—Mesalazine—Crohn's disease	0.00129	0.0014	CcSEcCtD
Oxycodone—Angioedema—Prednisone—Crohn's disease	0.00129	0.00139	CcSEcCtD
Oxycodone—Malaise—Prednisone—Crohn's disease	0.00127	0.00137	CcSEcCtD
Oxycodone—Vertigo—Prednisone—Crohn's disease	0.00127	0.00137	CcSEcCtD
Oxycodone—Syncope—Prednisone—Crohn's disease	0.00127	0.00137	CcSEcCtD
Oxycodone—Loss of consciousness—Prednisone—Crohn's disease	0.00124	0.00134	CcSEcCtD
Oxycodone—Convulsion—Prednisone—Crohn's disease	0.00122	0.00132	CcSEcCtD
Oxycodone—Arthralgia—Prednisone—Crohn's disease	0.0012	0.0013	CcSEcCtD
Oxycodone—Myalgia—Prednisone—Crohn's disease	0.0012	0.0013	CcSEcCtD
Oxycodone—Anxiety—Prednisone—Crohn's disease	0.0012	0.00129	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00119	0.00129	CcSEcCtD
Oxycodone—Discomfort—Prednisone—Crohn's disease	0.00119	0.00128	CcSEcCtD
Oxycodone—Oedema—Prednisone—Crohn's disease	0.00115	0.00124	CcSEcCtD
Oxycodone—Anaphylactic shock—Prednisone—Crohn's disease	0.00115	0.00124	CcSEcCtD
Oxycodone—Infection—Prednisone—Crohn's disease	0.00114	0.00124	CcSEcCtD
Oxycodone—Shock—Prednisone—Crohn's disease	0.00113	0.00122	CcSEcCtD
Oxycodone—Nervous system disorder—Prednisone—Crohn's disease	0.00113	0.00122	CcSEcCtD
Oxycodone—Tachycardia—Prednisone—Crohn's disease	0.00112	0.00121	CcSEcCtD
Oxycodone—Skin disorder—Prednisone—Crohn's disease	0.00112	0.00121	CcSEcCtD
Oxycodone—Hyperhidrosis—Prednisone—Crohn's disease	0.00111	0.0012	CcSEcCtD
Oxycodone—Anorexia—Prednisone—Crohn's disease	0.0011	0.00119	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.00105	0.00113	CcSEcCtD
Oxycodone—Insomnia—Prednisone—Crohn's disease	0.00104	0.00113	CcSEcCtD
Oxycodone—Paraesthesia—Prednisone—Crohn's disease	0.00103	0.00112	CcSEcCtD
Oxycodone—Dyspepsia—Prednisone—Crohn's disease	0.00101	0.0011	CcSEcCtD
Oxycodone—Decreased appetite—Prednisone—Crohn's disease	0.001	0.00108	CcSEcCtD
Oxycodone—Fatigue—Prednisone—Crohn's disease	0.000993	0.00107	CcSEcCtD
Oxycodone—Constipation—Prednisone—Crohn's disease	0.000985	0.00106	CcSEcCtD
Oxycodone—Feeling abnormal—Prednisone—Crohn's disease	0.000949	0.00103	CcSEcCtD
Oxycodone—Gastrointestinal pain—Prednisone—Crohn's disease	0.000942	0.00102	CcSEcCtD
Oxycodone—Urticaria—Prednisone—Crohn's disease	0.000915	0.000988	CcSEcCtD
Oxycodone—Abdominal pain—Prednisone—Crohn's disease	0.00091	0.000983	CcSEcCtD
Oxycodone—Body temperature increased—Prednisone—Crohn's disease	0.00091	0.000983	CcSEcCtD
Oxycodone—Hypersensitivity—Prednisone—Crohn's disease	0.000848	0.000917	CcSEcCtD
Oxycodone—Asthenia—Prednisone—Crohn's disease	0.000826	0.000893	CcSEcCtD
Oxycodone—Pruritus—Prednisone—Crohn's disease	0.000815	0.00088	CcSEcCtD
Oxycodone—Diarrhoea—Prednisone—Crohn's disease	0.000788	0.000851	CcSEcCtD
Oxycodone—Dizziness—Prednisone—Crohn's disease	0.000761	0.000823	CcSEcCtD
Oxycodone—Vomiting—Prednisone—Crohn's disease	0.000732	0.000791	CcSEcCtD
Oxycodone—Rash—Prednisone—Crohn's disease	0.000726	0.000784	CcSEcCtD
Oxycodone—Dermatitis—Prednisone—Crohn's disease	0.000725	0.000784	CcSEcCtD
Oxycodone—Headache—Prednisone—Crohn's disease	0.000721	0.000779	CcSEcCtD
Oxycodone—Nausea—Prednisone—Crohn's disease	0.000684	0.000739	CcSEcCtD
Oxycodone—OPRK1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.000645	0.0132	CbGpPWpGaD
Oxycodone—OPRM1—Peptide GPCRs—CCR6—Crohn's disease	0.000645	0.0132	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.000631	0.0129	CbGpPWpGaD
Oxycodone—OPRD1—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.000618	0.0127	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.000598	0.0123	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.000553	0.0113	CbGpPWpGaD
Oxycodone—OPRM1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.000545	0.0112	CbGpPWpGaD
Oxycodone—OPRK1—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.000542	0.0111	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.000524	0.0108	CbGpPWpGaD
Oxycodone—OPRD1—G alpha (i) signalling events—CCR9—Crohn's disease	0.000521	0.0107	CbGpPWpGaD
Oxycodone—OPRM1—IL4-mediated signaling events—SOCS1—Crohn's disease	0.000488	0.01	CbGpPWpGaD
Oxycodone—OPRD1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.000484	0.00992	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—ACKR2—Crohn's disease	0.00048	0.00985	CbGpPWpGaD
Oxycodone—OPRM1—TCR Signaling Pathway—IL17A—Crohn's disease	0.000478	0.00981	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.000467	0.00959	CbGpPWpGaD
Oxycodone—OPRM1—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.000458	0.00939	CbGpPWpGaD
Oxycodone—OPRK1—G alpha (i) signalling events—CCR9—Crohn's disease	0.000457	0.00938	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—MLN—Crohn's disease	0.000455	0.00934	CbGpPWpGaD
Oxycodone—OPRD1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00045	0.00922	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.000443	0.00909	CbGpPWpGaD
Oxycodone—OPRM1—IL4-mediated signaling events—IL10—Crohn's disease	0.000438	0.00898	CbGpPWpGaD
Oxycodone—OPRK1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.000424	0.0087	CbGpPWpGaD
Oxycodone—OPRM1—TCR Signaling Pathway—RIPK2—Crohn's disease	0.000424	0.0087	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—ACKR2—Crohn's disease	0.000421	0.00864	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.000414	0.0085	CbGpPWpGaD
Oxycodone—OPRD1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.000409	0.0084	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—MLN—Crohn's disease	0.000399	0.00819	CbGpPWpGaD
Oxycodone—OPRK1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.000394	0.00809	CbGpPWpGaD
Oxycodone—OPRM1—G alpha (i) signalling events—CCR9—Crohn's disease	0.000386	0.00792	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.000385	0.0079	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.000363	0.00745	CbGpPWpGaD
Oxycodone—OPRK1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.000359	0.00736	CbGpPWpGaD
Oxycodone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.000358	0.00735	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—ACKR2—Crohn's disease	0.000356	0.0073	CbGpPWpGaD
Oxycodone—OPRD1—G alpha (i) signalling events—CCR6—Crohn's disease	0.000345	0.00708	CbGpPWpGaD
Oxycodone—CYP3A7—Metapathway biotransformation—GPX4—Crohn's disease	0.000344	0.00706	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.000338	0.00693	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—MLN—Crohn's disease	0.000337	0.00692	CbGpPWpGaD
Oxycodone—OPRM1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.000333	0.00684	CbGpPWpGaD
Oxycodone—OPRD1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00032	0.00657	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—CCR9—Crohn's disease	0.000316	0.00647	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.000307	0.0063	CbGpPWpGaD
Oxycodone—OPRM1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.000303	0.00622	CbGpPWpGaD
Oxycodone—OPRK1—G alpha (i) signalling events—CCR6—Crohn's disease	0.000303	0.00621	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—GPR65—Crohn's disease	0.000293	0.00602	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.000285	0.00586	CbGpPWpGaD
Oxycodone—OPRD1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000282	0.00579	CbGpPWpGaD
Oxycodone—OPRK1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000281	0.00576	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—CCR9—Crohn's disease	0.000277	0.00568	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000274	0.00563	CbGpPWpGaD
Oxycodone—OPRM1—IL4-mediated signaling events—JAK2—Crohn's disease	0.000262	0.00538	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—MLN—Crohn's disease	0.000257	0.00528	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—GPR65—Crohn's disease	0.000257	0.00528	CbGpPWpGaD
Oxycodone—OPRM1—G alpha (i) signalling events—CCR6—Crohn's disease	0.000256	0.00525	CbGpPWpGaD
Oxycodone—CYP3A5—Metapathway biotransformation—GPX4—Crohn's disease	0.000249	0.0051	CbGpPWpGaD
Oxycodone—OPRK1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000247	0.00507	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—ACKR2—Crohn's disease	0.000246	0.00506	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000242	0.00496	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000241	0.00494	CbGpPWpGaD
Oxycodone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000237	0.00487	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—CCR9—Crohn's disease	0.000234	0.0048	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—MLN—Crohn's disease	0.000234	0.00479	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—MLN—Crohn's disease	0.000226	0.00463	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—GPR65—Crohn's disease	0.000217	0.00446	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—ACKR2—Crohn's disease	0.000216	0.00443	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000212	0.00435	CbGpPWpGaD
Oxycodone—OPRM1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000209	0.00429	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—CCR6—Crohn's disease	0.000209	0.00429	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—MLN—Crohn's disease	0.000205	0.0042	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000203	0.00417	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—MLN—Crohn's disease	0.000191	0.00391	CbGpPWpGaD
Oxycodone—OPRM1—TCR Signaling Pathway—CD4—Crohn's disease	0.000185	0.00379	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—PTGER4—Crohn's disease	0.000184	0.00378	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—CCR6—Crohn's disease	0.000183	0.00376	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—ACKR2—Crohn's disease	0.000183	0.00375	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000179	0.00367	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—CCR9—Crohn's disease	0.000178	0.00366	CbGpPWpGaD
Oxycodone—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	0.000177	0.00363	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—MLN—Crohn's disease	0.000173	0.00355	CbGpPWpGaD
Oxycodone—OPRM1—TCR Signaling Pathway—IL1B—Crohn's disease	0.00017	0.0035	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—GPR65—Crohn's disease	0.000166	0.0034	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CCR9—Crohn's disease	0.000162	0.00332	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—PTGER4—Crohn's disease	0.000161	0.00331	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—CCR9—Crohn's disease	0.000156	0.00321	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—CCR6—Crohn's disease	0.000155	0.00318	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—GPR65—Crohn's disease	0.000151	0.00309	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—ACKR2—Crohn's disease	0.000146	0.00299	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—GPR65—Crohn's disease	0.000145	0.00298	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CCR9—Crohn's disease	0.000142	0.00291	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MLN—Crohn's disease	0.000138	0.00283	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—PTGER4—Crohn's disease	0.000136	0.0028	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CCR9—Crohn's disease	0.000132	0.00271	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—GPR65—Crohn's disease	0.000132	0.00271	CbGpPWpGaD
Oxycodone—OPRD1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000132	0.00271	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ACKR2—Crohn's disease	0.000128	0.00262	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TAGAP—Crohn's disease	0.000126	0.00259	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—GPR65—Crohn's disease	0.000123	0.00252	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MLN—Crohn's disease	0.000121	0.00248	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CCR9—Crohn's disease	0.00012	0.00246	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—CCR6—Crohn's disease	0.000118	0.00242	CbGpPWpGaD
Oxycodone—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	0.000116	0.00237	CbGpPWpGaD
Oxycodone—OPRK1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000116	0.00237	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—GPR65—Crohn's disease	0.000112	0.00229	CbGpPWpGaD
Oxycodone—OPRD1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000111	0.00228	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TAGAP—Crohn's disease	0.000111	0.00227	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—RSPO3—Crohn's disease	0.00011	0.00226	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ACKR2—Crohn's disease	0.000108	0.00221	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CCR6—Crohn's disease	0.000107	0.0022	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SEL1L—Crohn's disease	0.000105	0.00215	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000104	0.00213	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—CCR6—Crohn's disease	0.000104	0.00213	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MLN—Crohn's disease	0.000102	0.0021	CbGpPWpGaD
Oxycodone—OPRM1—TCR Signaling Pathway—IL6—Crohn's disease	9.98e-05	0.00205	CbGpPWpGaD
Oxycodone—OPRM1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	9.77e-05	0.00201	CbGpPWpGaD
Oxycodone—OPRK1—G alpha (i) signalling events—CXCL8—Crohn's disease	9.76e-05	0.002	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—RSPO3—Crohn's disease	9.67e-05	0.00198	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PLA2G4F—Crohn's disease	9.62e-05	0.00197	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCR9—Crohn's disease	9.57e-05	0.00196	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—PTGER4—Crohn's disease	9.44e-05	0.00194	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CCR6—Crohn's disease	9.41e-05	0.00193	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TAGAP—Crohn's disease	9.35e-05	0.00192	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SEL1L—Crohn's disease	9.17e-05	0.00188	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—PTGER4—Crohn's disease	9.12e-05	0.00187	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—GPR65—Crohn's disease	8.89e-05	0.00182	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—IL3—Crohn's disease	8.86e-05	0.00182	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	8.85e-05	0.00181	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CCR6—Crohn's disease	8.75e-05	0.0018	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—RASGRP1—Crohn's disease	8.57e-05	0.00176	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCR9—Crohn's disease	8.39e-05	0.00172	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—PTGER4—Crohn's disease	8.28e-05	0.0017	CbGpPWpGaD
Oxycodone—OPRM1—G alpha (i) signalling events—CXCL8—Crohn's disease	8.24e-05	0.00169	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—MTMR3—Crohn's disease	8.18e-05	0.00168	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—RSPO3—Crohn's disease	8.18e-05	0.00168	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—IL3—Crohn's disease	8.04e-05	0.00165	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CCR6—Crohn's disease	7.95e-05	0.00163	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—GPR65—Crohn's disease	7.8e-05	0.0016	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—RASGRP1—Crohn's disease	7.78e-05	0.0016	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—IL3—Crohn's disease	7.77e-05	0.00159	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	7.76e-05	0.00159	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SEL1L—Crohn's disease	7.75e-05	0.00159	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—PTGER4—Crohn's disease	7.71e-05	0.00158	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—RASGRP1—Crohn's disease	7.51e-05	0.00154	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCR9—Crohn's disease	7.09e-05	0.00145	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—IL3—Crohn's disease	7.05e-05	0.00145	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PTGER4—Crohn's disease	7e-05	0.00144	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	6.96e-05	0.00143	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—RASGRP1—Crohn's disease	6.82e-05	0.0014	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—CXCL8—Crohn's disease	6.74e-05	0.00138	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—GPR65—Crohn's disease	6.59e-05	0.00135	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—IL3—Crohn's disease	6.56e-05	0.00135	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	6.56e-05	0.00134	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—FADS1—Crohn's disease	6.37e-05	0.00131	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	6.35e-05	0.0013	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCR6—Crohn's disease	6.34e-05	0.0013	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—IL2RA—Crohn's disease	6.21e-05	0.00127	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GPX4—Crohn's disease	5.97e-05	0.00122	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL3—Crohn's disease	5.96e-05	0.00122	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—MTMR3—Crohn's disease	5.91e-05	0.00121	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—CXCL8—Crohn's disease	5.91e-05	0.00121	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—RASGRP1—Crohn's disease	5.77e-05	0.00118	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GCKR—Crohn's disease	5.76e-05	0.00118	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—RBX1—Crohn's disease	5.73e-05	0.00118	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—IL2RA—Crohn's disease	5.64e-05	0.00116	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PTGER4—Crohn's disease	5.58e-05	0.00114	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCR6—Crohn's disease	5.56e-05	0.00114	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—IL2RA—Crohn's disease	5.44e-05	0.00112	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—RBX1—Crohn's disease	5.03e-05	0.00103	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—UBE2D1—Crohn's disease	5.03e-05	0.00103	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—CXCL8—Crohn's disease	4.99e-05	0.00102	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	4.95e-05	0.00101	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—IL2RA—Crohn's disease	4.94e-05	0.00101	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PTGER4—Crohn's disease	4.89e-05	0.001	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—RIPK2—Crohn's disease	4.87e-05	0.001	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL3—Crohn's disease	4.75e-05	0.000975	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCR6—Crohn's disease	4.7e-05	0.000963	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—FADS1—Crohn's disease	4.61e-05	0.000945	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—IL2RA—Crohn's disease	4.6e-05	0.000943	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—RASGRP1—Crohn's disease	4.6e-05	0.000943	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—UBE2D1—Crohn's disease	4.41e-05	0.000904	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GPX4—Crohn's disease	4.31e-05	0.000885	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—RIPK2—Crohn's disease	4.27e-05	0.000877	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—RBX1—Crohn's disease	4.25e-05	0.000871	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—MTMR3—Crohn's disease	4.21e-05	0.000863	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL2RA—Crohn's disease	4.18e-05	0.000857	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—JAK2—Crohn's disease	4.17e-05	0.000856	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL3—Crohn's disease	4.17e-05	0.000855	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GCKR—Crohn's disease	4.17e-05	0.000855	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SOCS1—Crohn's disease	4.16e-05	0.000854	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PTGER4—Crohn's disease	4.13e-05	0.000848	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—RASGRP1—Crohn's disease	4.03e-05	0.000827	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—TYK2—Crohn's disease	3.97e-05	0.000815	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—CXCL8—Crohn's disease	3.81e-05	0.000781	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—JAK2—Crohn's disease	3.79e-05	0.000777	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—UBE2D1—Crohn's disease	3.72e-05	0.000764	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—JAK2—Crohn's disease	3.66e-05	0.00075	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SOCS1—Crohn's disease	3.65e-05	0.000749	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—RIPK2—Crohn's disease	3.61e-05	0.000741	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SMAD3—Crohn's disease	3.6e-05	0.000738	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL3—Crohn's disease	3.52e-05	0.000722	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—TYK2—Crohn's disease	3.48e-05	0.000714	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CXCL8—Crohn's disease	3.46e-05	0.000709	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—RASGRP1—Crohn's disease	3.41e-05	0.000699	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—CXCL8—Crohn's disease	3.34e-05	0.000685	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL2RA—Crohn's disease	3.33e-05	0.000683	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—JAK2—Crohn's disease	3.32e-05	0.000681	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—FADS1—Crohn's disease	3.28e-05	0.000672	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	3.23e-05	0.000663	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SMAD3—Crohn's disease	3.15e-05	0.000647	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—JAK2—Crohn's disease	3.09e-05	0.000634	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SOCS1—Crohn's disease	3.09e-05	0.000633	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GPX4—Crohn's disease	3.07e-05	0.000629	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CXCL8—Crohn's disease	3.03e-05	0.000622	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GCKR—Crohn's disease	2.96e-05	0.000608	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—TYK2—Crohn's disease	2.94e-05	0.000604	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL2RA—Crohn's disease	2.92e-05	0.000599	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CXCL8—Crohn's disease	2.82e-05	0.000579	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—JAK2—Crohn's disease	2.81e-05	0.000576	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—MTMR3—Crohn's disease	2.75e-05	0.000564	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SMAD3—Crohn's disease	2.66e-05	0.000547	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CXCL8—Crohn's disease	2.56e-05	0.000526	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL2RA—Crohn's disease	2.47e-05	0.000506	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TYK2—Crohn's disease	2.35e-05	0.000481	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—JAK2—Crohn's disease	2.24e-05	0.000459	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—FADS1—Crohn's disease	2.14e-05	0.000439	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TYK2—Crohn's disease	2.06e-05	0.000422	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CXCL8—Crohn's disease	2.04e-05	0.000419	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GPX4—Crohn's disease	2.01e-05	0.000411	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—JAK2—Crohn's disease	1.96e-05	0.000403	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—IL6—Crohn's disease	1.94e-05	0.000398	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GCKR—Crohn's disease	1.94e-05	0.000397	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ALB—Crohn's disease	1.83e-05	0.000376	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CXCL8—Crohn's disease	1.79e-05	0.000367	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TYK2—Crohn's disease	1.74e-05	0.000357	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—IL6—Crohn's disease	1.7e-05	0.000349	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—JAK2—Crohn's disease	1.66e-05	0.00034	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—STAT3—Crohn's disease	1.64e-05	0.000337	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PTGS2—Crohn's disease	1.6e-05	0.000329	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CXCL8—Crohn's disease	1.51e-05	0.00031	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—STAT3—Crohn's disease	1.44e-05	0.000295	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL6—Crohn's disease	1.44e-05	0.000295	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ALB—Crohn's disease	1.33e-05	0.000272	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—STAT3—Crohn's disease	1.22e-05	0.00025	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PTGS2—Crohn's disease	1.16e-05	0.000238	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL6—Crohn's disease	1.15e-05	0.000235	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL6—Crohn's disease	1.01e-05	0.000206	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ALB—Crohn's disease	9.43e-06	0.000193	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL6—Crohn's disease	8.5e-06	0.000174	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PTGS2—Crohn's disease	8.25e-06	0.000169	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ALB—Crohn's disease	6.16e-06	0.000126	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PTGS2—Crohn's disease	5.39e-06	0.000111	CbGpPWpGaD
